Symetrex Long Term Hemodialysis Catheter
Medcomp (Dba Medical Components, Inc.)
FDA Clearance Information
The Symetrex Long Term Hemodialysis Catheter was cleared through the FDA's 510k pathway on November 16, 2017. It is manufactured by Medcomp and is classified as a Class 2 device under product code MSD.
What It Is
FDA-Cleared Indications
- Provides vascular access for hemodialysis in patients with chronic kidney disease.
- Intended for long-term hemodialysis access.
Clinical Applications
- Long-term central venous access for repeated hemodialysis treatments.
- Hemodialysis access for patients who do not have a usable arteriovenous fistula or graft.
- Hemodialysis access when a catheter is needed while permanent dialysis access is created or becomes usable.
- Dialysis access managed in a hospital or outpatient dialysis setting.
Practical Considerations
- The catheter is placed into a large central vein, commonly the internal jugular vein; other access sites may be selected based on the patient's anatomy and clinical history.
- Placement typically uses ultrasound and fluoroscopic or other radiographic guidance, with local anesthesia and moderate sedation or another anesthesia plan when appropriate.
- The catheter must be connected to compatible dialysis equipment and handled using strict sterile technique to reduce infection and catheter dysfunction.
- Potential complications include infection, thrombosis, bleeding, vessel injury, malposition and inadequate blood flow.
- MRI safety depends on the specific catheter configuration and labeling; the exact product instructions should be reviewed before MRI.
Frequently Asked Questions
What is the Symetrex Long Term Hemodialysis Catheter used for?
It is used to provide long-term vascular access for hemodialysis in patients with chronic kidney disease.
What specialties typically use this device?
Nephrologists and dialysis nurses typically use this device in dialysis centers and hospital settings.
What are the FDA-cleared indications?
The catheter is indicated for providing vascular access for hemodialysis in patients with chronic kidney disease, intended for long-term use.